Jacquelyne Garcia-Hernandez’s Post

Have you seen IMV's 2024 Nuclear Medicine Market Outlook Report? Dive deep into the latest trends, purchase plans, and industry insights shaping the future of nuclear medicine. Gain valuable perspectives from NM administrators and supervisors on department priorities, procedure volumes, and more. Don't miss out, get your copy here: https://hubs.la/Q02t0n5D0 #NuclearMedicine #MarketInsights #HealthcareTrends #IMVResearch

If your Health Institution specializes in nuclear medicine, you are in the right place! Come and see the Identisoft solutions that help in the visualization and analysis of exams whose modality is nuclear medicine. #identisoft #healthcare #hcaresolutions #medicalimaging #viewer #nuclearmedicine

CANDU technology doesn’t just produce power—it also co-produces medical isotopes. In fact, it is the only nuclear power reactor technology that has this ability. These are marvels of science that save people’s lives by fighting cancer. This is why our role as the stewards of CANDU technology is about more than commercialization or even supporting the energy transition. It becomes about delivering social value to local health networks and to the world. In fact, with an Industrial practice that helps producers set up facilities around the world in the life sciences and advanced manufacturing space, AtkinsRéalis is one of the few firms with a beginning-to-end perspective on nuclear medicine. #EngineeringaBetterFuture #CANDUMONARK #CanadiansForCANDU 

This month's issue of The Journal of Nuclear Medicine includes a supplement! Check out "Advancing Global Nuclear Medicine: The Role and Contributions of China" here: https://t.co/cImf05Z0Nm

UPDATE : OPAL Reactor Maintenance Extended to End of September ANSTO informed Nuclear Medicine Europe that the OPAL #reactor will resume service at the end of September due to the complex task of replacing and reconnecting the Cold Neutron Source (CNS). After OPAL's return, a 10-day irradiation and processing period is needed before #nuclearmedicine distribution can begin. Nuclear Medicine Europe (and its Emergency Response Team) reports no expected #supply disruptions and will update as needed. Read below the full statement. #isotopes #radiopharmaceuticals #molecularimaging

From what was seen at the 2024 European Congress of Nuclear Medicine. One of my goals as a nuclear physician businessman is to bring the technological advances and innovations of the specialty to Mexico by private sector. #nuclearmedicine #molecularimaging #theranostics #radionuclidetherapy #PETct

🚀 Dive deep into the future of nuclear medicine with IMV's 2024 Nuclear Medicine Market Outlook Report! Gain insights into department priorities, procedure trends, scanner purchase plans, and theranostics adoption to stay ahead in the industry. Don't miss out on the comprehensive analysis and market forecast scenarios for 2024-2026. Get your copy here: https://hubs.la/Q02sjNKm0 #NuclearMedicine #MarketOutlook #HealthcareIndustry #Theranostics

Nuclear medicine has revolutionised the treatment of many diseases. What is the global burden of nuclear medicine? See page 35 of the UNSCEAR document: https://buff.ly/3QDOARO #MedicalImagingAdvances #RadiologyExposureAnalysis #UNSCEARreport

Hello linkedin Friends 🤩 Due to the international shortage of Mo-99 production since the HRF reactor is currently under maintenance and inspection for next 4 weeks, Some departments utilize other option available from the cyclotron production; Tl-201 for MPI studies. I found this below guidelines from American Society of Nuclear Cardiology that might help you!